{
    "medicine_id": "f2e313599759d2ebd1c83f74087fa118fe7e1c37",
    "platform_id": "848",
    "metadata": {
        "name": "Serevent Accuhaler",
        "composition": "Serevent Accuhaler is a moulded plastic device containing a foil strip with regularly spaced blisters each containing 50 micrograms of salmeterol as xinafoate For the full list of",
        "clinical_particulars": {
            "therapeutic_indications": "Salmeterol is a selective \u03b2 2 agonist indicated for reversible airways obstruction in patients with asthma and chronic obstructive pulmonary disease COPD In asthma including nocturnal asthma and exercise induced symptoms it is indicated for those treated with inhaled corticosteroids who require a long acting beta agonist in accordance with current treatment guidelines Serevent Accuhaler is not a replacement for inhaled or oral corticosteroids which should be continued at the same dose and not stopped or reduced when treatment with Serevent Accuhaler is initiated",
            "contraindications": {
                "disease": "Hypersensitivity to salmeterol xinafoate or to any of the excipients listed in section 6 1",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Lactose (which contains milk protein).",
                "incompatibilities": "None reported."
            }
        },
        "revision_date": "2019-11-25"
    }
}